Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03540069 · ClinicalTrials.gov registry record · NA

Reducing Barriers and Sustaining Utilization of a Cervical Cancer Screening Program in Rural Senegal

A NA study of Cervical Cancer and Behavior, sponsored by University of Illinois at Chicago.

Completed
Registry status
NA
Development phase
160
Enrollment target
3
Study locations

NCT03540069: Completed NA study of Cervical Cancer and Behavior, sponsored by University of Illinois at Chicago.

NCT03540069 is a NA study of Cervical Cancer and Behavior that has completed, run by University of Illinois at Chicago. The registered enrollment target is 160 participants, below the 569-participant average among 144 other Cervical Cancer trials with a reported enrollment target (72% lower). The trial reports 3 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03540069, a NA study of Cervical Cancer and Behavior, has completed, sponsored by University of Illinois at Chicago.

COMPLETED
Registry status
NA
Development phase
160 participants
Enrollment target
3
Study locations

Study Summary

This research project will investigate the determinants of cervical cancer screening uptake and sustained utilization in this region and develop and evaluate a context-specific peer education behavioral intervention to improve uptake. Research supports the effectiveness of peer education in increasing cancer screening rates but, currently, no cervical cancer screening peer education program specific to rural Senegal exists. To inform the participatory development of this program, the investigators will assess barriers and facilitators of screening at multiple levels: individuals (women aged 30 to 59), households (family or principle social unit of at-risk women), and the community (immediate village or neighborhood with common amenities of at-risk women). We hypothesize that a peer education program that adapts to changing contexts over time and is targeted at a multi-level audience will result in early, widespread uptake and sustained use of the VIA cervical cancer screening program. Study findings will inform programmatic planning in Kedougou and the peer education curriculum we develop can serve as a template for maximizing early impact of new cervical cancer screening services implemented in other areas of rural Senegal. Our long-term goal is to inform national-level policy to guide the implementation of cervical cancer screening programs in other rural Senegal regions.

Primary Outcome

Number of women who are screened for cervical cancer

Conditions Studied

Interventions

  • BEHAVIORAL Care Group Cervical Cancer Screening Education Curriculum

Study Locations (3)

Other

  • Sénégal Ministère de la Santé et l'Action Sociale Département de Recherche - Dakar
  • Université Cheikh Anta Diop, Dakar, Senegal Cancer Institute & Institute of Health and Development - Dakar

Illinois

  • University of Illinois at Chicago - Chicago

Trial Details

FieldValue
Enrollment Target 160 participants
Start Date 2018-10-03
Est. Completion 2021-12-15
Phase NA
University of Illinois at Chicago

430 total trials

What the finished NCT03540069 record still lists

NCT03540069 is an interventional study that assigns participants to a tested intervention. The registered 160 participants enrollment target is mid-sized for trials with a published cap, below the 569-participant average among 144 other Cervical Cancer trials with a reported enrollment target (72% lower).

The record links to 2 conditions, with Cervical Cancer appearing as the primary indexed condition, and to 1 intervention - of which Care Group Cervical Cancer Screening Education Curriculum is the first listed.

NCT03540069 reports a single indexed study location in Other, Illinois.

Frequently Asked Questions

What is clinical trial NCT03540069 about?

NCT03540069 is a clinical study titled "Reducing Barriers and Sustaining Utilization of a Cervical Cancer Screening Program in Rural Senegal". This research project will investigate the determinants of cervical cancer screening uptake and sustained utilization in this region and develop and evaluate a context-specific peer education behavioral intervention to improve uptake. Research supports the effectiveness of peer education in increasi...

What is the current status of trial NCT03540069?

This trial is currently completed. It is a NA study. The enrollment target is 160 participants. The study started on 2018-10-03. Estimated completion is 2021-12-15.

What conditions does trial NCT03540069 study?

This clinical trial studies the following conditions: Cervical Cancer, Behavior.

What interventions are being tested in trial NCT03540069?

The interventions under investigation include: Care Group Cervical Cancer Screening Education Curriculum (BEHAVIORAL).

Who is sponsoring clinical trial NCT03540069?

This trial is sponsored by University of Illinois at Chicago, which has 430 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03540069 being conducted?

This trial has 3 study locations across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cervical Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT03540069's enrollment target sits among peer trials

160 53rd of 144 higher than 92 of 144 other Cervical Cancer trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Cervical Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00501826 · 160 participants · Phase 2

    Combination Chemotherapy and Nelarabine in Treating Patients With T-cell Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma

  • NCT00932139 · 160 participants · NA

    Effect of Electro-Acupuncture on Blood Pressure

  • NCT00992901 · 160 participants · Early Phase 1

    Role of Neural and Hormonal Regulation Factors on Insulin Secretion After Gastric Bypass Surgery

  • NCT01515527 · 160 participants · Phase 2

    Cladribine Plus Low Dose Cytarabine (LDAC) Alternating With Decitabine in Patients With Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndrome (MDS)

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03540069, the US trial registry maintained by the National Library of Medicine. NCT03540069 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.